Effect of a new lipid-reducing preparation (Etofibrat) on hyperlipoproteinemia type II. 2
Knüchel, F.
Die Medizinische Welt 25(44): 1810-1812
1974
ISSN/ISBN: 0025-8512 PMID: 4372508 Document Number: 79611
Document emailed within 1 workday
Related Documents
Mertz, D.P.; Loewer, H.; Suermann, I. 1979: The range and lipid-lowering effect of etofibrate as a retard-preparation in patients with hyperlipoproteinemia type IIa Medizinische Klinik 74(51-52): 1953-1956Sobra, J.; Jílek, M. 1971: Inborn defectx of lipid metabolism. 23. Coincidence of type 3 hyperlipoproteinemia and albinism Casopis Lekaru Ceskych 110(19): 451-453
Bassett, D.R.; Block, W.D.; Dean, E.N.; White, A.A. 1990: Recognition of borderline carbohydrate-lipid metabolism disturbance: an incipient form of type IV hyperlipoproteinemia? Journal of Cardiovascular Pharmacology 15(Suppl 5): S8-17
Zeman, M.; Zák, A.; Stolba, P. 1995: The effect of polyene phosphatidylcholine administration on lipid metabolism and glucose tolerance in patients with hyperlipoproteinemia IIB Sbornik Lekarsky 96(1): 43-48
Klebanova, E.M.; Balabolkin, M.I.; Kreminskaia, V.M.; Smirnov, L.D. 2006: Lipid reducing and antioxidant action of mexicor in patients with diabetes mellitus type 2 Terapevticheskii Arkhiv 78(8): 67-70
Shinomiya, M.; Ishikawa, Y.; Shirai, K.; Saito, Y.; Yoshida, S. 1987: Effect of pirozadil on lipids, lipoproteins and apolipoproteins in Japanese with type IIa hyperlipoproteinemia Arzneimittel-Forschung 37(9): 1069-1071
Haacke, H.; Parwaresch, M.R.; Mäder, C. 1976: The effect of xanthinol nicotinate on the serum lipids and lipoproteins of patients with primary hyperlipoproteinemia Type IIb and IV Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 1: 829-832
Kwiterovich, P.O.; Bachorik, P.S.; Franklin, F.A.; Margolis, S.; Georgopoulos, L.; Teng, B.; Sniderman, A.D. 1985: Effect of dietary treatment on the plasma levels of lipids, lipoprotein cholesterol and LDL B protein in children with type Ii hyperlipoproteinemia Progress in Clinical and Biological Research 188: 123-137
Sindelka, G.; Skrha, J.; Hilgertová, J.; Justová, V. 1997: The effect of a short-term reducing diet on the effect of insulin in type 2 diabetes mellitus Casopis Lekaru Ceskych 136(17): 530-532
Bolzano, K.; Krempler, F.; Schellenberg, B.; Schlierf, G. 1979: A comparison of bezafibrate and clofibrate in type Ii B and type IV hyperlipoproteinemia Acta Medica Austriaca 6(3): 90-94
Arntz, H.R.; Klemens, U.H.; Vollmar, L.J.; Lang, P.D. 1978: Comparison of clofibrate and bezafibrate in type IIa and type IIb hyperlipoproteinemia Medizinische Klinik 73(49): 1731-1737
L'vovskaia, E.I.; Efimenko, G.P.; Lifshits, R.I. 1995: The effect of the BITO preparation and various serum antioxidants on the intensity of lipid peroxidation in thermal trauma Voprosy Meditsinskoi Khimii 41(3): 31-34
Mitra, S.K.; Gopumadhavan, S.; Muralidhar, T.S.; Anturlikar, S.D.; Sujatha, M.B. 1995: Effect of D-400, a herbomineral preparation on lipid profile, glycated haemoglobin and glucose tolerance in streptozotocin induced diabetes in rats Indian Journal of Experimental Biology 33(10): 798-800
Ivanova, I.L.; Ian'kova, V.I.; Knyshova, V.V.; Kozlovskaia, E.P. 2000: A specialized product with antioxidant action in the treatment of lipid disorders in experimental hyperlipoproteinemia Voprosy Pitaniia 69(1-2): 13-15
Weisweiler, P. 1985: Dietary treatment of hyperlipoproteinemia. Reduction of atherogenic lipid fractions in normal subjects Fortschritte der Medizin 103(7): 148-150
Apostolov, I.; Goranov, I.; Balabanski, L.; Krŭsteva, A.; Popova, D. 1982: Serum lipid studies of hyperlipoproteinemia patients during diet therapy with pectin preparations Vutreshni Bolesti 21(1): 51-54
Bustos, P.; Fernández, E.; Radrigán, E. 1987: Hyperlipoproteinemia type i Revista Chilena de Pediatria 58(6): 481-484
Heckers, H.; Oehler, G. 1975: Type-V-hyperlipoproteinemia Die Medizinische Welt 26(39): 1766-1774
Calderín, F.M.; Perianes, J.; Nuño, J.; De Oya, M. 1977: Hyperlipoproteinemia type i Revista Clinica Espanola 147(1): 81-84
Matsuura, F. 2007: Familial hyperlipoproteinemia, type IV Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 7): 326-328